Neoadjuvant Sintilimab Plus Chemoradiotherapy for Locally Advanced Adenocarcinoma of Esophagogastric Junction

Conditions

• PD-1
• Neoadjuvant Chemoradiotherapy
• Gastroesophageal Junction Cancer

Interventions

• DRUG: PD-1inhibitor

Sponsor

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology